MD Anderson and Texas Children’s Hospital announce joint venture focused on childhood cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital have announced a collaboration focused on pediatric cancer care. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Thyme Care expanded its survivorship program and comprehensive cancer care services with the appointment of two experienced medical directors: Asma Dilawari as medical director of oncology care, who will lead the company’s survivorship program expansion, and Nelia Jain as medical director of palliative care, who will scale Thyme Care’s virtual palliative care offering, called Enhanced Supportive Care. 
First-line treatment with the triplet combination of encorafenib, cetuximab, and mFOLFOX6 significantly improved survival compared to the standard of care in patients with BRAF V600E-mutated metastatic colorectal cancer, according to new data from the phase III BREAKWATER trial led by researchers from the University of Texas MD Anderson Cancer Center.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login